January 24, 2025
A win for Ontario’s life sciences sector! Brian Bloom, Chairman and Chief Executive Officer of Bloom Burton & Co., comments in The Globe and Mail on AstraZeneca’s (LSE, NASDAQ: AZN) $820-million investment, supporting the company’s expansion to a larger facility in the Greater Toronto Area.